Hypoglycemia has been a significant barrier for many patients with diabetes. It commonly occurs in patients with type 1 and type 2 diabetes using insulin or insulin secretagogues. By completing this module, clinicians will get a better understanding on the latest evidence on hypoglycemia and its management in type 2 diabetes patients.
This program is developed in collaboration with Partners in Progressive Medical Education, and endorsed by Diabetes Canada.
This program has received an educational grant or in-kind support from Abbott Diabetes Care, Astra Zeneca, Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc., Janssen, Novo Nordisk and Sanofi.